These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7905233)
1. Necrotizing vasculitis--relapse despite cytotoxic therapy. Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Bacon PA Adv Exp Med Biol; 1993; 336():477-81. PubMed ID: 7905233 [TBL] [Abstract][Full Text] [Related]
2. Relapses in patients with a systemic vasculitis. Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA Q J Med; 1993 Dec; 86(12):779-89. PubMed ID: 7906421 [TBL] [Abstract][Full Text] [Related]
3. Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks. Kaeser HE Eur Neurol; 1984; 23(6):407-9. PubMed ID: 6150853 [TBL] [Abstract][Full Text] [Related]
4. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Adu D; Pall A; Luqmani RA; Richards NT; Howie AJ; Emery P; Michael J; Savage CO; Bacon PA QJM; 1997 Jun; 90(6):401-9. PubMed ID: 9205678 [TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. Fauci AS; Katz P; Haynes BF; Wolff SM N Engl J Med; 1979 Aug; 301(5):235-8. PubMed ID: 36563 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C; N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090 [TBL] [Abstract][Full Text] [Related]
10. Infectious complications of cyclophosphamide treatment for vasculitis. Bradley JD; Brandt KD; Katz BP Arthritis Rheum; 1989 Jan; 32(1):45-53. PubMed ID: 2563226 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids. Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH; Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953 [TBL] [Abstract][Full Text] [Related]
12. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy. Akova YA; Jabbur NS; Foster CS Ophthalmology; 1993 Dec; 100(12):1775-81. PubMed ID: 7903120 [TBL] [Abstract][Full Text] [Related]
13. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Bleeker-Rovers CP; Bredie SJ; van der Meer JW; Corstens FH; Oyen WJ Am J Med; 2004 Jan; 116(1):50-3. PubMed ID: 14706666 [No Abstract] [Full Text] [Related]
14. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data. de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502 [TBL] [Abstract][Full Text] [Related]
15. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B; Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782 [TBL] [Abstract][Full Text] [Related]